Who Owns Innate Pharma S.A. (IPHA)?Hedge Fund & Institutional Holders
Institutional Holders
14
as of Q4 2025
Total Institutional Value
$14249110.0T
% of Float Held
—
QoQ Change in Holders
+5 / -3
Price History
IPHA — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Lion Point Capital, LP | New Position | +81K | +$142K |
| OLD MISSION CAPITAL LLC | New Position | +28K | +$49K |
| MILLENNIUM MANAGEMENT LLC | New Position | +20K | +$0 |
| JANE STREET GROUP, LLC | New Position | +93K | +$0 |
| SageView Advisory Group, LLC | New Position | +1 | +$0 |
| RHUMBLINE ADVISERS | Increased | +5K | +$-916K |
IPHA — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| MORGAN STANLEY | Decreased | -7K | -$103.4M |
| CITADEL ADVISORS LLC | Closed Position | -20K | -$39.1M |
| UBS Group AG | Decreased | -4K | -$9.3M |
| GAMMA Investing LLC | Decreased | -1K | -$4.4M |
| BARCLAYS PLC | Decreased | -306 | -$593K |
| Optiver Holding B.V. | Closed Position | -101 | -$197K |
| PRINCIPAL SECURITIES, INC. | Closed Position | -45 | -$87K |
Top Institutional Holders(Q4 2025)
| # | Fund | Shares | Value | % of Portfolio | Type |
|---|---|---|---|---|---|
| 1 | Lion Point Capital, LP | 81,151 | $142K | 0.73% | Share |
| 2 | OLD MISSION CAPITAL LLC | 28,431 | $49K | 0.00% | Share |
| 3 | GAMMA Investing LLC | 1,073 | $1K | 0.00% | Share |
| 4 | UBS Group AG | 801 | $1K | 0.00% | Share |
| 5 | UBS Group AG | 146 | $0 | 0.00% | Share |
| 6 | JANE STREET GROUP, LLC | 277 | $0 | 0.00% | Share |
| 7 | RHUMBLINE ADVISERS | 5,204 | $0 | 0.00% | Share |
| 8 | MILLENNIUM MANAGEMENT LLC | 20,308 | $0 | 0.00% | Share |
| 9 | MORGAN STANLEY | 43,524 | $0 | 0.00% | Share |
| 10 | MORGAN STANLEY | 2,870 | $0 | 0.00% | Share |
| 11 | JANE STREET GROUP, LLC | 92,476 | $0 | 0.00% | Share |
| 12 | Farther Finance Advisors, LLC | 10 | $0 | 0.00% | Share |
| 13 | SageView Advisory Group, LLC | 1 | $0 | 0.00% | Share |
| 14 | BARCLAYS PLC | 1 | $0 | 0.00% | Share |
IPHA Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 11 | $193K | +2 |
| Q3 2025 | 9 | $157.9M | +1 |
| Q2 2025 | 8 | $85.2M | -2 |
| Q1 2025 | 10 | $279.3M | +0 |
| Q4 2024 | 10 | $143.2B | +1 |
| Q3 2024 | 9 | $344.8B | +0 |
| Q2 2024 | 9 | $298.0B | -1 |
| Q1 2024 | 10 | $495.2B | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 14 institutional investors hold IPHA (Innate Pharma S.A.). The largest holder is Lion Point Capital, LP with $142K in shares. This quarter, 5 institutions opened new positions and 3 closed their positions.
Frequently Asked Questions
How many hedge funds own IPHA?
As of Q4 2025, 14 institutional investors report holding IPHA (Innate Pharma S.A.) in their 13F filings.
Who is the largest institutional holder of IPHA?
The largest institutional holder of IPHA is Lion Point Capital, LP with $142K in shares.
Is institutional ownership of IPHA increasing or decreasing?
This quarter, 5 institutions opened new positions in IPHA and 3 closed their positions.